TVARDI THERAPEUTICS, INC. (TVRD) Return on equity 2016–2022
TVARDI THERAPEUTICS, INC. (TVRD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-53.8%FY2022 · since FY2016: -112.9% → -53.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -53.8% | -15.0 pp |
| FY2021 | -38.9% | -42.2 pp |
| FY2020 | 3.4% | +60.3 pp |
| FY2019 | -57.0% | -1.6 pp |
| FY2018 | -55.4% | +11.6 pp |
| FY2017 | -67.0% | +45.9 pp |
| FY2016 | -112.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice